Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus Type for High-Protein Meal in T1D Children
NCT02276859Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart, insulin lispro and insulin glulisine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Postprandial glycemia at 180 months. Started Oct 2014; status: completed.
02
Drugs
insulin aspartinsulin lisproinsulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02276859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276859.